State Of Alaska, Department Of Revenue Collegium Pharmaceutical, Inc Transaction History
State Of Alaska, Department Of Revenue
- $9.35 Billion
- Q2 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 19,127 shares of COLL stock, worth $617,037. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,127
Previous 17,870
7.03%
Holding current value
$617,037
Previous $533,000
5.82%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding COLL
# of Institutions
253Shares Held
37.2MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$187 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$96.8 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$85.2 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$72.5 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$52.7 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.1B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...